Sort
23,748 grants matching “melanoma”
SSW Works: A Virtual Learning Environment for Occupational Skin Cancer Prevention
$979,566Mary K Buller · Klein Buendel, Inc. · R44 · FY2022 · CA
Immunology of aging and immunotherapy of aging-associated diseases
$979,308Arya Biragyn · National Institute On Aging · ZIA · FY2023 · AG
Bifunctional T cell receptor based immunotherapeutics
$979,275Hing C. Wong · Altor Bioscience. Llc · R44 · FY2011 · CA
Improving the Efficacy of Dendritic Cell Vaccines
$978,697Jacques F Banchereau · Baylor Research Institute · P01 · FY2007 · CA
Rapid 3D POC digital cancer pathology by unique confocal microscopy instrumentation and downstream AI: a simple, efficient, robust direct-to-digital approach to meet market demand
$978,154Daniel Summer Gareau · Surgivance, Inc. · R44 · FY2025 · CA
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$977,964Tomas G Neilan · Massachusetts General Hospital · R01 · FY2023 · HL
ROLE OF LILRB4 IN MELANOMA. NEW AWARD.
$977,866The University Of Texas Southwestern Medical Center · · FY2020 · Defense Health Agency
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
$977,758Jessie Villanueva · Wistar Institute · R01 · FY2025 · CA
Combining receptor-targeted alpha particle therapy and immunotherapy to achieve complete responses in metastatic melanoma
$976,668Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2022 · CA
DCTD Human Toxicology and Pharmacology
$976,485David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
The Laboratory of Stem Cell Biology
$975,474Mahendra Rao · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2012 · AR
Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma
$974,959Yen Tun Wang · Curebiotech, Inc. · R44 · FY2020 · CA
Genetic Epidemiology
$974,906Alisa Goldstein · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center)
$974,841Peter Karl Sorger · Harvard Medical School · U2C · FY2020 · CA
Lead optimization of novel ML-IAP antagonists to treat lung cancer
$974,339Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA
Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis
$974,241Kurt Kohn · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Impact of Vaccination against GM2, GD2 and GD3 on Disease Free Survival in Resect
$973,936Wolfgang W Scholz · Mabvax Therapeutics, Inc. · R44 · FY2011 · CA
T-Cell Receptor Gene Therapy for Human Cancers-Cures
$973,782James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Cell Prep Core
$973,443John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Cell Production Facility Core
$973,441Mark Dudley · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Postmortem Pathology
$973,411David E Kleiner · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Identification of Lethal Melanomas at the Time of Diagnosis
$972,565Nancy E Thomas · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Regulation of Ras-Dependent Signal Transduction Pathways
$972,526Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
IN VIVO IMAGING OF SINGLE CIRCULATING CELLS
$972,047Lihong Wang · Washington University · R01 · FY2013 · CA
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$971,495Tomas G Neilan · Massachusetts General Hospital · R01 · FY2024 · HL